Ogkologos

4397 ΔΗΜΟΣΙΕΥΣΕΙΣ 0 ΣΧΟΛΙΑ

‘Being open will help bring awareness’: Meet the fashion vlogger who...

Ogkologos - 16 Νοεμβρίου, 2022

Cancer research could revive the UK’s ailing public finances

Ogkologos - 16 Νοεμβρίου, 2022

Duration of Bevacizumab Maintenance of 15 Months Remains the Standard in...

Ogkologos - 16 Νοεμβρίου, 2022

FDA Approves Tremelimumab in Combination with Durvalumab and Platinum-Based Chemotherapy for...

Ogkologos - 15 Νοεμβρίου, 2022

Can Fertility Drugs or IVF Increase My Risk for Cancer?

Ogkologos - 15 Νοεμβρίου, 2022

COVID-19 Vaccines Are Safe for People Receiving Cancer Immunotherapy, Study Confirms

Ogkologos - 15 Νοεμβρίου, 2022

Adding Tremelimumab to Durvalumab and Chemotherapy Provides Survival Benefit for Patients...

Ogkologos - 15 Νοεμβρίου, 2022

Research with integrity – the importance of communication

Ogkologos - 14 Νοεμβρίου, 2022

NICE recommends pembrolizumab for 1,600 more people with breast cancer

Ogkologos - 14 Νοεμβρίου, 2022

EMA Recommends Extension of Therapeutic Indications for Trastuzumab Deruxtecan

Ogkologos - 14 Νοεμβρίου, 2022

1...165166167...440 Σελίδα 166 από 440

MOST POPULAR

FDA Approves Revumenib for Relapsed or Refractory Acute Leukaemia with a...

10 Δεκεμβρίου, 2024

More Than 25 Additional Years Needed to Slow an Increasing Incidence...

8 Σεπτεμβρίου, 2021

Glucose Control Key in Reducing Cancer Risk for People with Type...

7 Δεκεμβρίου, 2021

Partnering with Small Business to Advance Innovation in Cancer Research and...

21 Φεβρουαρίου, 2019

Φόρτωση περισσοτέρων

‘Being open will help bring awareness’: Meet the fashion vlogger who...

Cancer research could revive the UK’s ailing public finances

Duration of Bevacizumab Maintenance of 15 Months Remains the Standard in...

FDA Approves Tremelimumab in Combination with Durvalumab and Platinum-Based Chemotherapy for...

Can Fertility Drugs or IVF Increase My Risk for Cancer?

COVID-19 Vaccines Are Safe for People Receiving Cancer Immunotherapy, Study Confirms

Adding Tremelimumab to Durvalumab and Chemotherapy Provides Survival Benefit for Patients...

Research with integrity – the importance of communication

NICE recommends pembrolizumab for 1,600 more people with breast cancer

EMA Recommends Extension of Therapeutic Indications for Trastuzumab Deruxtecan

MOST POPULAR

FDA Approves Revumenib for Relapsed or Refractory Acute Leukaemia with a...

More Than 25 Additional Years Needed to Slow an Increasing Incidence...

Glucose Control Key in Reducing Cancer Risk for People with Type...

Partnering with Small Business to Advance Innovation in Cancer Research and...

HOT NEWS

Dr Ian Walker on Smoking: ‘A political no-brainer’

El cáncer en mi comunidad: Superar los retrasos en la atención...

FDA Approves Isatuximab-irfc for Subcutaneous Injection for Multiple Myeloma Indications

Activity and Safety of Regorafenib Plus Nivolumab in First-Line Treatment for...

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ